Sustainability & Climate

A South Carolina community built around a working farm just won two of the nation's highest homebuilding awards, cementing the Agrihood as the future of living.

New data on leronlimab reveals striking long-term survival signals in heavily pretreated mTNBC patients, hinting at a new way to fight the disease.

Hair Cuttery Family of Brands is rolling out amika products in 500+ salons, a strategic move to meet demand for premium, inclusive haircare for all.

Despite a reported net loss, the REIT saw a 162% jump in key operational funds and a 22% surge in its senior housing portfolio's income.

India's largest newspaper group wins a top CSR award, but it's the citizen-led campaigns behind the win that reveal a new model for media's social impact.

With its NAD+ technology featured in Forbes, biotech brand Aramore is challenging marketing hype with scientific rigor and a vision for longevity.

ABLi Therapeutics reports its drug risvodetinib is the first to lower toxic alpha-synuclein levels in a Phase 2 trial, heralding a new era for patients.

enGene hits the road for key investor conferences, showcasing a promising non-viral gene therapy for a tough-to-treat bladder cancer. Will it succeed?

Following massive asset sales and billions in dividends, Array Digital reports surging tower revenue and an optimistic forecast for its new 5G future.

Stunning high-grade gold samples, including one at 250 g/t, prompt Yukon Metals to consolidate a historic mining area near Whitehorse.

New research reveals how clinical trial design inflates the placebo effect, offering a key to solving the 90% failure rate for anxiety and depression drugs.

A NJ practice is targeting the hidden crisis of eating disorders in men and athletes, offering specialized virtual care to break down stigma and access barriers.

After 65 years, Generac is a finalist for Wisconsin's top manufacturing award, lauded for its tech innovation, economic impact, and community investment.

A new stamp-sized oral film could replace the dreaded epinephrine needle. Aquestive's Anaphylm shows promise, but faces regulatory and market hurdles.

A new partnership will supply Japan's surging cell therapy sector with critical, GMP-grade materials, aiming to accelerate the path from lab to clinic.

Global distributor IMCD deepens its food and nutrition footprint with the strategic acquisition of Willows Ingredients, targeting high-growth niche markets.

A landmark agreement sees Tla’amin Nation acquire a massive forest tenure, blending traditional stewardship with a new model for BC's forestry industry.

UDC's 11% dividend hike marks its eighth straight year of increases, reflecting deep confidence in the booming, multi-billion dollar OLED technology market.

A landmark bill to shield living organ donors from job and insurance discrimination is advancing in the Senate, offering new hope for 90,000+ on the waiting list.

With a securitization 5x oversubscribed, Kiavi unlocks $1.2B in new funding, proving investor confidence in its AI-powered real estate lending platform.